MBCOF (Marvel Biosciences) Total Assets: $0.34 Mil (As of Apr. 2026)


MBCOF Marvel Biosciences Corp MBCOF
34 GF Score
Price $0.11
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences Total Assets?

Marvel Biosciences MBCOF 34 Total Assets is $0.34 Mil as of Apr. 2026. GuruFocus rates MBCOF with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Marvel Biosciences's Total Assets for the quarter that ended in Apr. 2026 was $0.34 Mil.

During the past 12 months, Marvel Biosciences's average Total Assets Growth Rate was 36.60% per year. During the past 3 years, the average Total Assets Growth Rate was -14.90% per year. During the past 5 years, the average Total Assets Growth Rate was 19.00% per year.

During the past 6 years, Marvel Biosciences's highest 3-Year average Total Assets Growth Rate was 24.60%. The lowest was -14.90%. And the median was 17.40%.

Total Assets is connected with ROA %. Marvel Biosciences's annualized ROA % for the quarter that ended in Apr. 2026 was 442.43%. Total Assets is also linked to Revenue through Asset Turnover. Marvel Biosciences's Asset Turnover for the quarter that ended in Apr. 2026 was 0.00.

Marvel Biosciences  (OTCPK:MBCOF) Total Assets Explanation

Total Assets is connected with ROA %.

Marvel Biosciences's annualized ROA % for the quarter that ended in Apr. 2026 is

ROA %=Net Income (Q: Apr. 2026 )/( (Total Assets (Q: Jan. 2026 )+Total Assets (Q: Apr. 2026 ))/ count )
=1.272/( (0.232+0.343)/ 2 )
=1.272/0.2875
=442.43 %

Note: The Net Income data used here is four times the quarterly (Apr. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Marvel Biosciences's Asset Turnover for the quarter that ended in Apr. 2026 is

Asset Turnover
=Revenue (Q: Apr. 2026 )/( (Total Assets (Q: Jan. 2026 )+Total Assets (Q: Apr. 2026 ))/ count )
=0/( (0.232+0.343)/ 2 )
=0/0.2875
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Marvel Biosciences Total Assets Related Terms

Marvel Biosciences Total Assets Historical Data

* Premium members only.

The historical data trend for Marvel Biosciences's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences Total Assets Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Total Assets
Get a 7-Day Free Trial 1.97 0.71 0.51 0.36 0.24

Marvel Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.24 0.49 0.23 0.34
MBCOF
34GF Score
Marvel Biosciences Corp MBCOF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marvel Biosciences Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Marvel Biosciences's Total Assets for the fiscal year that ended in Jul. 2025 is calculated as

Total Assets=Total Equity (A: Jul. 2025 )+Total Liabilities (A: Jul. 2025 )
=-2.926+3.165
=0.24

Marvel Biosciences's Total Assets for the quarter that ended in Apr. 2026 is calculated as

Total Assets=Total Equity (Q: Apr. 2026 )+Total Liabilities (Q: Apr. 2026 )
=-1.988+2.331
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $0.34 Mil mean?
Marvel Biosciences (MBCOF) has a Total Assets of $0.34 Mil as of Apr. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Marvel Biosciences and its competitors.
Is Marvel Biosciences' Total Assets too high?
Marvel Biosciences' current Total Assets is $0.34 Mil. Overall, Marvel Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' Total Assets compare to VRTX and REGN?
Marvel Biosciences' Total Assets of $0.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Marvel Biosciences and its competitors. Marvel Biosciences's current Total Assets is $0.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current Total Assets of $0.34 Mil. The current Total Assets is $0.34 Mil. Marvel Biosciences' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current Total Assets is $0.34 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marvel Biosciences Business Description

Other Exchanges MRVL:Canada
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
34GF Score

Get the complete analysis for MBCOF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price